Skip to main content
ArticleOPEN ACCESS

Haplo-BMT: Cure or back to sickle cell?

Blood
DOI: 10.1182/blood-2012-09-455832
9Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

In this issue of Blood, Bolaños-Meade et al report promising results using a pioneering HLA-haploidentical bone marrow transplantation protocol in adults with sickle cell disease (SCD), including nonmyeloablative conditioning and posttransplantation high-dose cyclophosphamide.

Cite

CITATION STYLE

APA

Bernaudin, F., & Kuentz, M. (2012, November 22). Haplo-BMT: Cure or back to sickle cell? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-09-455832

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free